Alessia Surgo

ORCID: 0000-0003-4502-9635
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Cardiac electrophysiology and arrhythmias
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Advances in Oncology and Radiotherapy
  • Colorectal and Anal Carcinomas
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging Techniques and Applications
  • COVID-19 and healthcare impacts
  • Endometrial and Cervical Cancer Treatments
  • Breast Cancer Treatment Studies
  • Cardiac pacing and defibrillation studies
  • Colorectal Cancer Surgical Treatments
  • Radiation Dose and Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Diagnosis and Treatment
  • Radiation Therapy and Dosimetry
  • Management of metastatic bone disease
  • Breast Implant and Reconstruction

Ospedale Generale Regionale Francesco Miulli
2020-2024

Libera Università Maria SS. Assunta
2024

European Institute of Oncology
2013-2020

University of Milan
2015-2019

Istituti di Ricovero e Cura a Carattere Scientifico
2018-2019

Ripamonti
2018-2019

University of Bari Aldo Moro
2011

Background/Objectives: Hypofractionated radiation therapy (Hypo-RT) schedules may offer radiobiological, patient convenience, and healthcare resource advantages over standard fractionated (S-RT) for glioblastoma (GBM). Additionally, simulated integrated boost (SIB) Hypo-RT is proven to be an effective safe treatment. We report on our experience regarding progression-free survival (PFS), overall (OS), RT-related toxicities in GBM patients treated with S-RT. Methods: Patients IDH-wildtype...

10.20944/preprints202502.0397.v1 preprint EN 2025-02-06

Background: This study investigated the risk of reconstruction failure after mastectomy, immediate breast reconstruction, and radiotherapy to either a temporary tissue expander or permanent implant. Methods: Records women treated at single institution between June 1997 December 2011 were reviewed. Two patient groups identified based on type reconstruction: followed by exchange with implant The endpoint was rate failure, defined as replacement, loss implant, conversion flap. Results:...

10.1097/prs.0000000000006441 article EN Plastic & Reconstructive Surgery 2019-11-28

Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal excision followed by radiochemotherapy, in 30 fractions, the standard approach. Limited data are present literature about hypofractionated radiotherapy (hypo-RT) GBM poor prognosis patients. Thus, this retrospective study was conducted to evaluate efficacy and toxicity of hypo-RT with simultaneous integrated boost (SIB) association temozolomide (TMZ) patient setting.Poor-prognosis patients underwent surgery (complete,...

10.3390/jpm11111145 article EN Journal of Personalized Medicine 2021-11-04

Abstract Aims Stereotactic arrhythmia radioablation (STAR) is a novel therapeutic approach for cardiac arrhythmias. The aim of this trial to investigate the feasibility STAR treatment paroxysmal atrial fibrillation (AF) in elderly patients. Methods and results Inclusion criteria were age >70 years, symptomatic AF, antiarrhythmic drugs failure, or intolerance. All patients underwent 4D computed tomography simulation. clinical target volume was identified area around pulmonary veins...

10.1093/europace/euad344 article EN cc-by EP Europace 2023-11-21

Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. reported data of the first 5 worldwide, showed no side effects, absence AF episodes and without antiarrhythmic drugs.ClinicalTrials.gov, identifier: NCT04575662.

10.3389/fcvm.2022.832446 article EN cc-by Frontiers in Cardiovascular Medicine 2022-03-02

Sustained monomorphic ventricular tachycardia (SMVT) is a life-threatening condition that often observed in patients with structural heart disease. Catheter ablation (CA) an effective and well-established treatment for the scar-related tachycardias (VTs). Sometimes, due to patient fragility or contraindications CA, noninvasive procedure required. In these cases, VT stereotactic arrhythmia radioablation (STAR) SMVTs supported by CardioInsight mapping system seems be promising approach.

10.3390/jcdd11080239 article EN cc-by Journal of Cardiovascular Development and Disease 2024-08-05
Coming Soon ...